期刊文献+

硫鱼精蛋白去除OPV中Vero细胞基质DNA的研究 被引量:4

Study on Removing Residual DNA of Vero Cells in OPV with Protamine Sulphate
原文传递
导出
摘要 以不同浓度的硫鱼精蛋白(PS)对Vero细胞制备的Ⅰ,Ⅱ,Ⅲ型脊髓灰质炎口服活疫苗(OPV)病毒悬液进行后处理去除细胞基质DNA研究.PS浓度大于1mg/mL,纯化后疫苗中DNA残余含量低于100pg/剂量.随着病毒液中PS浓度的增加,DNA残余含量减少,但病毒回收率亦降低.结果表明PS沉淀法,病毒回收率高,DNA残余含量能达到WHO规程DNA限量要求,对脊灰病毒rct/40特征及病毒壳蛋白等生物学性状无显著影响。 The effect of different concentrations of PS on the removal of cellular DNA from types Ⅰ, Ⅱ and Ⅲ OPV produced on Vero cells was examined.It was found that 1?mg/mL PS was able to remove residual cell DNA to meet the WHO requirements (content of DNA <100?pg/dose) and when PS concentrati on was increased,the DNA content and virus recovery rate decreased.It also show ed that the treatment of OPV with PS has no influence on rct/40 character and vi ral capsid.We demonstrated that precipitation of OPV with PS is simple method f or eliminating residual cellular DNA in OPV preparation on Vero cell.
出处 《云南大学学报(自然科学版)》 CAS CSCD 1999年第3期192-194,共3页 Journal of Yunnan University(Natural Sciences Edition)
关键词 脊髓灰质炎 硫鱼精蛋白 OPV 疫苗 VERO细胞 cellular substrate DNA OPV protamine sulphate
  • 相关文献

参考文献2

  • 1黄祯祥,医学病毒学基础及实验技术,1990年,308页
  • 2顾方舟,脊髓灰质炎,1984年,382页

同被引文献31

  • 1韩德胜,李振平,李薇,孙燕,孙振鹏,崔焰,王玉琳.硫酸鱼精蛋白去除Vero细胞乙脑疫苗残余DNA方法的条件优化[J].微生物学免疫学进展,2007,35(4):14-18. 被引量:4
  • 2董荫良,钱兴丽,侯宗柳,车艳春,邵聪文.口服液体型脊髓灰质炎减毒活疫苗的稳定性研究[J].中国计划免疫,2004,10(4):232-233. 被引量:3
  • 3米贤文,王永生,欧阳运富,段于峰.8-羟基脱氧鸟苷与鱼精蛋白相互作用的研究及其分析应用[J].中国卫生检验杂志,2007,17(8):1381-1383. 被引量:2
  • 4Kh an AS. Characterization and qualification of cell substrates for manufacturing viral vaccines in the United States [J]. Bio- process J, 2009, 8 (3): 8-12.
  • 5US. Department of Heahh and Human Services FI)A, CBER. Guidance for industry :characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications [ S ]. 2010-02.
  • 6WHO. Requirements for rabies vaccine (inactivated) for human use produced in continuous cell lines [S]. WHO TRS, Annex 9, 1987, No. 760.
  • 7European Pharmacopoeia Commission. European Pharmacopoeia [S]. 6. 0, Vol. 1. Strasbourg: EDQM, 2008: 836-838.
  • 8Chtioui M, Trabelsi K, Kallel H. Purification of rabies virus produced on Vero cells using chromatography techniques [J]. Cell Technology for Cell Products, 2007,3 : 629-634.
  • 9Fabre V, Rocca C, Riffard P, et all. Method for purifying the rabies virus [P]. WO 2010116096, 2010-10-14.
  • 10WHO. Recommendations for the evaluation of animal cell cul- tures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks [S]. WHO TRS, Annexl, 2010, No. 878.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部